Jingya Li

Title: Jingya Li: Innovator in Pharmaceutical Compounds

Introduction

Jingya Li is a notable inventor based in Zhengzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various diseases. With a total of 2 patents, his work focuses on innovative solutions for treating neurodegenerative diseases and cancers.

Latest Patents

One of Jingya Li's latest patents involves a [1,3]thiazin-2-amine compound, which is directed towards applications and pharmaceutical compositions. This invention is particularly relevant in the field of BACE inhibitors. The compound, represented by formula (I) or its pharmaceutically acceptable salts, stereoisomers, solvates, or prodrugs, demonstrates a strong inhibitory effect on BACE. It holds potential for preparing medicaments aimed at treating neurodegenerative diseases, such as Alzheimer's disease.

Another significant patent by Jingya Li includes bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinase. This invention discloses novel bis-quinazoline derivatives that serve as tyrosine kinase inhibitors. The synthesis of these compounds and innovative methods for treating tyrosine kinase-mediated diseases or disorders are also covered. Specifically, the invention provides tethered quinazoline derivative dimers as inhibitors to the EGFR tyrosine kinase, along with pharmaceutical compositions and therapeutic uses for treating various cancers.

Career Highlights

Jingya Li has worked with Tetranov International Inc. and Tetranov Pharmaceutical Co., Ltd., where he has contributed to the advancement of pharmaceutical research and development. His expertise in creating effective compounds has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Jingya Li has collaborated with notable professionals, including Yusheng Wu and Chengshan Niu. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Jingya Li's innovative work in developing pharmaceutical compounds showcases his commitment to addressing critical health challenges. His contributions to the field of medicine through his patents reflect his dedication to improving treatment options for neurodegenerative diseases and cancers.